ARVN
ARVINAS, INC.
Nasdaq Pharmaceutical Preparations Accelerated filer

Key Financials

Net Income
$-80800000
↑ 59.4%
Revenue
$262.6M
↓ 0.3%
EPS (Diluted)
$-1.14
↑ 58.8%
Operating Income
$-118500000
↑ 52.6%
Total Liabilities
$284.0M
↓ 46.4%
Shareholders' Equity
$433.9M
↓ 22.8%
Cash & Equivalents
$142.9M
↑ 42.2%
Operating Cash Flow
$-273800000.00
↓ 5.6%

Recent SEC Filings

Form Type Filed Date Link
4 6/26/2026 View on SEC
4 6/26/2026 View on SEC
4 6/26/2026 View on SEC
4 6/26/2026 View on SEC
4 6/26/2026 View on SEC
4 6/26/2026 View on SEC
8-K 6/25/2026 View on SEC
4 6/24/2026 View on SEC
144 6/23/2026 View on SEC
8-K 6/22/2026 View on SEC

Company Information

Field Value
Ticker ARVN
Company Name ARVINAS, INC.
CIK 1655759
Sector Pharmaceutical Preparations
Industry Accelerated filer
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 203-535-1456